Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 1/2012

01-02-2012 | Nephrology - Original Paper

Simple assessment of patient’s stage of chronic kidney disease using eGFR-MDRD nomograms

Authors: Sunny Eloot, Bruno Van Vlem, Johan De Meester

Published in: International Urology and Nephrology | Issue 1/2012

Login to get access

Abstract

European as well as US guidelines recommend the Modification of Diet in Renal Disease (MDRD) formula to determine the glomerular filtration rate (GFR) and, based on this, the staging of chronic kidney disease (CKD). The diagnosis of CKD is only established when a reduced eGFR has been observed for 3 months or longer. Because the MDRD equation is very complex, the calculation of eGFR is not possible without help from calculators or computers. Therefore, we converted this equation into simple, easy to use colour nomograms. These were drawn separately for men and women, on one hand, and for whites and blacks, on the other. These nomograms allow the determination of a patient’s eGFR in a quick and easy way and at any location.
Literature
1.
Bjornsson TD (1979) Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 4:200–222PubMedCrossRef
2.
Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concept. Clin Chem 38:1933–1953PubMed
3.
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
4.
Gates GF (1985) Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function. Am J Kidney Dis 5:199–205PubMed
5.
Jelliffe RW, Jelliffe SM (1972) A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight. Math Biosc 14:17–24CrossRef
6.
Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMed
7.
Salazar DE, Corcoran GB (1988) Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 84:1053–1060PubMedCrossRef
8.
Wright JG, Boddy AV, Highley M et al (2001) Estimation of glomerular filtration rate in cancer patients. Br J Cancer 84:452–459PubMedCrossRef
9.
European Best Practice guidelines (2002) Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transpl 17:7–15
10.
K/DOQI clinical practice guidelines for chronic kidney disease (2002) Evaluation, classification and stratification: kidney disease outcome quality initiative. Am J Kidney Dis 39:S1–S266CrossRef
11.
Levey AS, Greene T, Kusek J et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:A0828
12.
Levey AS, Coresh J, Greene T et al (2006) Chronic kidney disease epidemiology collaboration: using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMed
13.
Agaba EI, Wigwe CM, Agaba PA, Tzamaloukas AH (2009) Performance of the Cockcroft-Gault and MDRD equations in adult Nigerians with chronic kidney disease. Int Urol Nephrol 41(3):635–642PubMedCrossRef
14.
Wieczorowska-Tobis K, Niemir ZI, Guzik P et al (2006) Difference in estimated GFR with two different formulas in elderly individuals. Int Urol Nephrol 38(2):381–385PubMedCrossRef
Metadata
Title
Simple assessment of patient’s stage of chronic kidney disease using eGFR-MDRD nomograms
Authors
Sunny Eloot
Bruno Van Vlem
Johan De Meester
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9849-x

Other articles of this Issue 1/2012

International Urology and Nephrology 1/2012 Go to the issue

Nephrology – Original Paper

Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country

Nephrology – Letter to the Editor

Aspirin resistance in hemodialysis patients

Nephrology – Original Paper

Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up

Publisher’s Announcement

Change in Editorship

Urology – Review

Robot-assisted partial nephrectomy: current status, techniques, and future directions

Nephrology – Original Paper

Factors associated with diabetic nephropathy in subjects with proliferative retinopathy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits